Radiotherapy Market Size

Statistics for the 2023 & 2024 Radiotherapy market size, created by Mordor Intelligence™ Industry Reports. Radiotherapy size report includes a market forecast to 2029 and historical overview. Get a sample of this industry size analysis as a free report PDF download.

Market Size of Radiotherapy Industry

Radiotherapy Market Summary
share button
Study Period 2019 - 2029
Market Size (2024) USD 10.18 Billion
Market Size (2029) USD 12.51 Billion
CAGR (2024 - 2029) 4.20 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players


*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Radiotherapy Market Analysis

The Radiotherapy Market size is estimated at USD 10.18 billion in 2024, and is expected to reach USD 12.51 billion by 2029, growing at a CAGR of 4.20% during the forecast period (2024-2029).

Initially, the COVID-19 pandemic has had a significant impact on the radiotherapy market owing to the disruption of the supply chain of radiotherapy devices and consumables, which led to shortages and delivery delays. For instance, according to the article published by the NCBI in February 2022, the COVID-19 restrictions imposed on hospitals the oncologic care, including radiation therapy, was severely affected as many hospitals and clinics diverted their resources to COVID-19 treatment, leading to a reduced capacity for radiotherapy services. However, with the wide adoption of telemedicine and the surge in various research studies, the radiotherapy market has picked up a significant growth pace and is expected to follow the same trend during the forecast period.

The major factors driving the market growth include increasing incidence of cancer, extensive research and development (R&D) pipelines, and rising awareness about cancer among the target population.

Radiotherapy is a significant treatment option for various cancers, such as breast, prostate, lung, and brain tumors which is expected to drive the market growth over the forecast period. For instance, as per the article published by the WHO in September 2022, breast cancer is the most commonly diagnosed cancer type, accounting for 1 in 8 cancer diagnoses worldwide. As per the same source, the estimated breast cancer burden will increase to more than 3 million new cases per year, an increase of 40%.

Similarly, the rising advancements in radiotherapy devices are expected to fuel their adoption across radiotherapy centers, hence contributing to the market growth. For instance, as per the article published by the Dovepress journal in April 2022, it was observed that the developments in radiotherapy devices such as multileaf collimator, integration of imaging techniques like computed tomography (CT), positron emission tomography (PET), and involvement of advanced dose calculation algorithms, and delivery techniques have increased tumor dose distribution and decreased normal tissue toxicity. This provides effective management of cancer to the target population with enhanced patient survival and improved quality of life.

Furthermore, the same source reported that intensity-modulated radiotherapy (IMRT), three-dimensional conformal radiotherapy (3DCRT), particle therapy, stereotactic radiotherapy, and image-guided radiotherapy (IGT) have also facilitated the planning procedures, accurate tumor delineation, and dose estimation for effective personalized treatment. Therefore, with the increase in the prevalence of cancer, advancements in technology, and expansion of access to healthcare facilities, the radiotherapy market is projected to register significant growth during the forecast period.

Moreover, the increased R&D is predicted to drive the demand for radiotherapy over the forecast period. For instance, in August 2021, Manipal Hospitals, India's second-largest multi-specialty hospital, launched an advanced Radixact System that comes with Synchrony Automatic, Real-time Motion Synchronization Technology for the precise treatment of cancer patients. By precisely targeting the tumor location, which moves with breathing, with high-precision radiation, the method minimizes damage to healthy tissue. Manipal Hospitals has obtained the requisite license from the Atomic Energy Regulatory Board (AERB) for Radixact X9 Tomotherapy with Synchrony tumor tracking technology, India's first machine with this feature. Thus, such advancements and developments in radiotherapy are expected to drive market growth.

Therefore, the studied market is expected to register significant growth over the forecast period due to the above-mentioned factors. However, the lack of skilled personnel to perform radiotherapy is further expected to hinder the market growth over the forecast period.

Radiotherapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)